Synergistic activation of the tumor suppressor, HLJ1, by the transcription factors YY1 and activator protein 1

Cancer Research

Volumn 67, Issue 10, 2007, Pages 4816-4826

  Wang, Chi Chung ^a   Tsai, Meng Feng ^d   Dai, Ting Hao ^e   Hong, Tse Ming ^a   Chan, Wing Kai ^b   Chen, Jeremy J W ^a,e   Yang, Pan Chyr ^a,b,c,f  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^c INSTITUTE OF BIOMEDICAL SCIENCES   (Taiwan)

^d DA YEH UNIVERSITY   (Taiwan)

^e NATIONAL CHUNG HSING UNIVERSITY   (Taiwan)

^f NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CURVED DNA; PROTEIN P300; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR FOSB; TRANSCRIPTION FACTOR FRA 1; TRANSCRIPTION FACTOR JUNB; TRANSCRIPTION FACTOR JUND; TRANSCRIPTION FACTOR YY1; TUMOR SUPPRESSOR PROTEIN; TUMOR SUPPRESSOR PROTEIN HLJ 1; UNCLASSIFIED DRUG;

ANGIOGENESIS; ARTICLE; CANCER INVASION; CARCINOGENESIS; CELL INVASION; CELL PROLIFERATION; CHROMATIN IMMUNOPRECIPITATION; COMPLEX FORMATION; CONTROLLED STUDY; DNA FLANKING REGION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; METASTASIS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN EXPRESSION; UPREGULATION;

ADENOCARCINOMA; BASE SEQUENCE; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; ENHANCER ELEMENTS (GENETICS); GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, TUMOR SUPPRESSOR; HSP40 HEAT-SHOCK PROTEINS; HUMANS; LIVER NEOPLASMS; LUNG NEOPLASMS; MOLECULAR SEQUENCE DATA; PROMOTER REGIONS (GENETICS); PROTO-ONCOGENE PROTEINS C-FOS; PROTO-ONCOGENE PROTEINS C-JUN; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION FACTOR AP-1; TRANSFECTION; UP-REGULATION; YY1 TRANSCRIPTION FACTOR;

EID: 34250376736     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-07-0504     Document Type: Article

References (39)

1. Morimoto RI. Cells in stress: transcriptional activation of heat shock genes. Science 1993;259:1409-10.
2. Jolly C, Morimoto RI. Role of the heat shock response and molecular chaperones in oncogenesis and cell death. J Natl Cancer Inst 2000;92:1564-72.
3. Csermely P, Schnaider T, Soti C, Prohaszka Z, Nardai G. The 90-kDa molecular chaperone family: structure, function, and clinical applications. A comprehensive review. Pharmacol Ther 1998;79:129-68.
4. Kiang J, Tsokos G. Heat shock protein 70 kDa: molecular biology, biochemistry, and physiology. Pharmacol Ther 1998;80:183-201.
5. Lindquist S, Craig EA. The heat shock proteins. Annu Rev Genet 1988;22:631-77.
6. Robert J. Evolution of heat shock protein and immunity. Dev Comp Immunol 2003;27:449-64.
7. Helmbrecht K, Zeise E, Rensing L. Chaperones in cell cycle regulation and mitogenic signal transduction: a review. Cell Prolif 2000;33:341-65.
8. Neininger A, Gaestel M. Evidence for a hsp25-specific mechanism involved in transcriptional activation by heat shock. Exp Cell Res 1998;242:285-93.
9. Hoe KL, Won M, Chung KS, et al. Isolation of a new member of DnaJ-like heat shock protein 40 (Hsp40) from human liver. Biochim Biophys Acta 1998;1383:4-8.
10. Miernyk JA. The J-domain proteins of Arabidopsis thaliana: an unexpectedly large and diverse family of chaperones. Cell Stress Chaperones 2001;6:209-18.
11. Borges JC, Peroto MC, Ramos CHI. Molecular chaperone genes in the sugarcane expressed sequence database (SUCEST). Gen Mol Biol 2001;24:85-92.
12. Venter JC, Adams MD, Myers EW, et al. The sequence of the human genome. Science 2001;291: 1304-51.
13. Tsai MF, Wang CC, Chang GC, et al. A new tumor suppressor DnaJ-like heat shock protein, HLJ1, and survival of patients with non-small-cell lung carcinoma. J Natl Cancer Inst 2006;98:825-38.
14. Wang CC, Tsai MF, Hong TM, et al. The transcriptional factor YY1 upregulates the novel invasion suppressor HLJ1 expression and inhibits cancer cell invasion. Oncogene 2005;24:4081-93.
15. Li JJ, Westergaard C, Ghosh P, Colburn NH. Inhibitors of both nuclear factor-κB and activator protein-1 activation block the neoplastic transformation response. Cancer Res 1997;57:3569-76.
16. Li JJ, Rhim JS, Schlegel R, Vousden KH, Colburn NH. Expression of dominant negative Jun inhibits elevated AP-1 and NF-κB transactivation and suppresses anchorage independent growth of HPV immortalized human keratinocytes. Oncogene 1998;16: 2711-21.
17. Li J, Cho Y, Young MR, Colburn NH. Induced expression of dominant-negative c-jun downregulates NFκB and AP-1 target genes and suppresses tumor phenotype in human keratinocytes. Mol Carcinog 2000; 29:159-69.
18. Chu YW, Yang PC, Yang SC, et al. Selection of invasive and metastatic subpopulations from a human lung adenocarcinoma cell line. Am J Respir Cell Mol Biol 1997;17:353-60.
19. Quandt K, Frech K, Karas H, Wingender E, Werner T. MatInd and MatInspector. Nucleic Acids Res 1995;23: 4878-84.
20. Prestridge DS. SIGNAL SCAN: A computer program that scans DNA sequences for eukaryotic transcriptional elements. Comput Appl Biosci 1991;7:203-6.
21. Heinemeyer T, Chen X, Karas H, et al. Expanding the TRANSFAC database towards an expert system of regulatory molecular mechanisms. Nucleic Acids Res 1999;27:318-22.
22. Chen JJW, Yao PL, Yuan A, et al. Up-regulation of tumor interleukin-8 expression by infiltrating macrophages: its correlation with tumor angiogenesis and patient survival in non-small cell lung cancer. Clin Cancer Res 2003;9:729-37.
23. Alvarez-Salas LM, Benitez-Hess ML, Dipaolo JA. YY-1 and c-Jun transcription factors participate in the repression of the human involucrin promoter. Int J Oncol 2005;26:259-66.
24. Kang JH, Chang SY, Yeom DH, Kim SA, Um SJ, Hong KJ. Weakening of the repressive YY-1 site on the thrombospondin-1 promoter via c-Jun/YY-1 interaction. Exp Mol Med 2004;36:300-10.
25. Lee JS, See RH, Deng T, Shi Y. Adenovirus E1A downregulates cJun- and JunB-mediated transcription by targeting their coactivator p300. Mol Cell Biol 1996; 16:4312-26.
26. Albini A, Pfeffer U. A new tumor suppressor gene: invasion, metastasis, and angiogenesis as potential key targets. J Natl Cancer Inst 2006;98:800-1.
27. Welter JF, Crish JF, Agarwal C, Eckert RL. Fos-related Antigen (Fra-1), junB, and junD activate human involucrin promoter transcription by binding to proximal and distal AP1 sites to mediate phorbol ester effects on promoter activity. J Biol Chem 1995;270: 12614-22.
28. Eferl R, Wagner EF. AP-1: a double-edged sword in tumorigenesis. Nat Rev Cancer 2003;11:859-68.
29. INK4a expression. EMBO J 2000;19:2969-79.
30. Shaulian E, Karin M. AP-1 in cell proliferation and survival. Oncogene 2001;20:2390-400.
31. Heinrich R, Livne E, Ben-Izhak O, Aronheim A. The c-Jun dimerization protein 2 inhibits cell transformation and acts as a tumor suppressor gene. J Biol Chem 2004; 279:5708-15.
32. Ameyar-Zazoua M, Wisniewska MB, Bakiri L, Wagner EF, Yaniv M, Weitzman JB. AP-1 dimers regulate transcription of the p14/p19ARF tumor suppressor gene. Oncogene 2005;24:2298-306.
33. Wang CC, Chen JJW, Yang PC. Multi-functional transcription factor YY1: a therapeutic target in human cancer? Expert Opin Ther Targets 2006;10: 253-66.
34. Seligson D, Horvath S, Huerta-Yepez S, et al. Expression of transcription factor Yin-Yang 1 in prostate cancer. Int J Oncol 2005;27:131-41.
35. Querfurth HW, Jiang J, Xia W, Selkoe DJ. Enhancer function and novel DNA binding protein activity in the near upstream βAPP gene promoter. Gene 1999;232: 125-41.
36. Barton MC, Madani N, Emerson BM. Distal enhancer regulation by promoter derepression in topologically constrained DNA in vitro. Proc Natl Acad Sci U S A 1997; 94:7257-62.
37. Willis SD, Seyfred MA. Pituitary-specific chromatin structure of the rat prolactin distal enhancer element. Nucleic Acids Res 1996;24:1065-72.
38. Campling BG, El-Deiry WS. Clinical implication of p53 mutation in lung cancer. Mol Biotechnol 2003;24: 141-56.
39. Deng CX. BRCA1: cell cycle checkpoint, genetic-instability, DNA damage response and cancer evolution. Nucleic Acids Res 2006;34:1416-26.